Brief: European Patent Office Intends To Grant NextCell Pharma Patent For Selection Algorithm

NextCell Pharma AB

31/05/2022 07:48

May 31 (Reuters) - NextCell Pharma AB  NXTCL.ST :
    * THE EUROPEAN PATENT OFFICE INTENDS TO GRANT A PATENT FOR
SELECTION ALGORITHM
    * EUROPEAN PATENT OFFICE (EPO) HAS ISSUED AN INTENTION TO
GRANT
NOTICE RELATING TO PATENT ENTITLED "ALLOGENEIC COMPOSITION"
    * PATENT PROTECTION IS VALID UNTIL 2039
    * PATENT DESCRIBES METHOD OF MANUFACTURING DRUG CANDIDATE
PROTRANS, WHERE SELECTION ALGORITHM IS KEY FOR SELECTING OPTIMAL
CELLS AND DONORS

Source text for Eikon:  ID:nWkr95FcsL 
Further company coverage:  NXTCL.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))